Milestone an important step in launching Trinovium within the global AI data center ecosystem-Data center liquid cooling market projected to ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Trinity Biotech ( (TRIB)) has ...

Trinity Biotech plc, a biotechnology company focusing on human diagnostics and diabetes management, has announced a significant update to its Comprehensive Transformation Plan, which includes ...

Trinity Biotech, a Nasdaq-listed biotechnology company focused on human diagnostics and diabetes management solutions, this ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and the development of innovative solutions addressing unmet clinical and industrial needs, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Irish company had operated ...

-Trinity Biotech (TRIB) projects it reached Adjusted EBITDA 1-positive operations during Q2 2025 and expects to be Adjusted EBITDA 1 positive going forward, reflecting continued strong execution on ...

New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and high-per ...

The Company expects Quarter 4, 2025 revenue within the range of approximately $11.5 million to $12.5 million. This compares to Quarter 4, 2024 revenue of $15.9 million, which was driven by a ...

Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets – Company publishes Q1 2026 financial results with revenue in line with prior ...

Trinity Biotech plc (TRIB Quick Quote TRIB - Free Report) has announced the acquisition of privately held Irish deep-tech company Metabolomics Diagnostics. The acquired company specializes in the ...